Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
miR-218, miR-146, and miR-222 expression before and after valproate treatment in women with epilepsy and relation to polycystic ovary syndrome
IRCT20190213042701N1Phase 3Completed
- Sponsor
- Yazd Reproductive Sciences Institute
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of valproic acid in epilepsy (2 arms), sponsored by Yazd Reproductive Sciences Institute. Started Sep 2016; status: completed.
02
Drugs
valproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20190213042701N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190213042701N1.